Abstract
Infliximab is effective in human and murine IBD, but its pharmacodynamic is still poorly known. The aim of this study was to assess the affinity of infliximab to murine TNF-α, its role in murine colitis when administered intra-rectally and its levels in the blood, gut mucosa and stool of healthy and sick mice.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 1017-1021 |
| Numero di pagine | 5 |
| Rivista | Digestive and Liver Disease |
| Volume | 45 |
| Numero di pubblicazione | 12 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2013 |
All Science Journal Classification (ASJC) codes
- Epatologia
- Gastroenterologia
Keywords
- Faeces
- Inflammatory bowel disease
- Infliximab
- Intestinal mucosa
- Murine DSS colitis
- Pharmacokinetic
- Serum levels